Portal hypertension is a serious condition that is most commonly a result of cirrhosis. It is defined as an increase in portal venous pressure that impedes blood flow into the liver. This review describes portal hypertension and its typical etiologies. Twodimensional and Doppler sonography play important roles in the diagnosis and surveillance of patients with portal hypertension.
in an adult with portal vein thrombosis. Patients who have undergone splenectomy are at risk for splenic or portal vein thrombosis. Umbilical catheters in newborns are also associated with portal vein thrombosis.
Hepatic etiologies are divided into those that occur before and those that occur at the level of the sinusoids. Sinusoids are small capillaries that run between hepatocytes. They form part of the pathway of blood as it travels from portal to hepatic veins. Schistosomiasis is an example of an intrahepatic presinusoidal etiology for portal hypertension. This is a parasite that breeches the wall of small liver vessels, which in turn causes fibrosis in the periportal tissue and portal venous obstruction. 4 Schistosomiasis is common in countries with poor water quality. Biliary cirrhosis is another cause of intrahepatic presinusoidal portal hypertension. This condition can be primary (cause unknown) or secondary from biliary stones, strictures, or neoplasm. The periportal bile ducts become inflamed and scarred. The most common cause of portal hypertension in North America is cirrhosis. 2, 3 Cirrhosis is most often the result of alcohol abuse. Other frequent causes of cirrhosis include hepatitis B and C. 5, 6 Cirrhosis is a diffuse process characterized by progressive parenchymal injury, fibrosis, and nodular regeneration. In the process, the hepatic architecture is distorted and the sinusoids are compressed, which leads to an increase in portal venous pressure. Additionally, the increase in splanchnic circulation seen in cirrhosis contributes to higher portal pressure. [1] [2] [3] Diffuse metastatic disease may also distort, compress, or invade the portal radicals.
Postsinusoidal etiologies are uncommon. They include Budd Chiari syndrome and constrictive pericarditis. Budd Chiari syndrome develops when the hepatic veins become obstructed. This may occur as a result of coagulation anomalies, malignancy, or membranes. 3 Constrictive pericarditis is a cardiac condition in which the outer shell of the heart is stiff and filling is impaired. Both result in higher proximal pressure in the portal system.
Sonography
Sonography plays an important role in the detection and follow-up of patients with suspected portal hypertension. It is nonionizing, noninvasive, inexpensive, and portable compared with other modalities. 3 Two-dimensional (2D) sonographic imaging is used to determine the etiology, if possible, of portal hypertension and to document primary and secondary features. Pulsed-wave and color Doppler are invaluable in identifying the presence and direction of blood flow in the portal venous system. 2D and Doppler sonography together with patient history contribute to the diagnosis of this serious disease.
A complete abdominal survey for portal hypertension includes gray scale and Doppler imaging. The liver must be carefully assessed for texture and size. The use of low-frequency transducers to enhance penetration is often essential. Intercostal windows are often necessary to get closer to a small high liver. The spleen must be imaged for splenomegaly and the extent of any ascites documented. Doppler documents the presence and direction of flow in the portal system and patency of the hepatic veins. Color and/or pulsed-wave Doppler is most useful for this task. The following veins must be surveyed: splenic, superior mesenteric, main, right and left portal, and hepatic. Flow in the portal veins is normally hepatopetal or into the liver. Flow in the main portal vein is continuous and slightly pulsatile with minimal respiratory variations. Scanner sensitivity for these naturally low velocities must be optimized. Color gain must be set high enough to record flow. It is suggested that the gain be turned up until color appears in the tissue and then reduced slightly to remove artifactual echoes. Velocity scale and wall filters must be set low. The use of the appropriate scanner preset program usually sets the scale and filters to the optimal starting level. A word of advice: do not use the invert function for abdominal Doppler. The accepted standard is that blood moving toward the transducer is displayed as red and that moving away is shown as blue. Using the invert function for color or pulsed-wave Doppler in the abdomen complicates the already difficult task of identifying flow direction in vessels.
The examination begins with the gray-scale identification of the cause of portal hypertension; the most common cause is cirrhosis. The sonographic features of cirrhosis are well accepted, although core biopsy is required for a definitive histologic diagnosis. The finding of a small echogenic liver with a nodular surface is typical for cirrhosis ( Fig. 2A) . Several secondary features accompany the primary finding in portal hypertension, most commonly splenomegaly, ascites, and varices. 1, 3, [5] [6] [7] Splenomegaly is passive enlargement as a result of the increased pressure downstream in the portal vein ( Fig. 2B ). There is no correlation, however, between spleen size and the severity of portal pressure increase. 8 Ascites is the result of liver failure.
Varices are veins that dilate in response to increased pressure farther along the portal system. They occur proximal to the site of increased pressure and divert blood away from the liver into the systemic venous system. Varices are reported to occur in 39% of patients with biopsy-proven cirrhosis and are more common in patients with advanced disease. 5 Splenorenal varices are the most common, seen in 21% of patients with spontaneous shunts. 5 These varices shunt blood from the splenic vein to the left renal vein, diverting the blood toward the inferior vena cava (IVC). The sonographic findings of splenomegaly and dilated tortuous veins in the splenic hilum are highly suggestive of portal hypertension. Color or pulsed-wave Doppler can confirm the vascular nature of the splenorenal varices. They are red and blue as they wind toward and away from the transducer (Fig. 3 ).
The next most common collateral pathway is the paraumbilical vein, seen in 14% of patients with shunts. 5 This vein is continuous with the ascending portion of the left portal vein in the inferior aspect of the left intersegmental fissure. It travels through the ligamentum teres and then runs within the falciform ligament to the umbilicus. The paraumbilical vein ends at the umbilicus in a caput medusae. Blood is directed from the caput medusae back toward the IVC, again bypassing the liver. Early studies by Lafortune and colleagues 7 confirmed that the fetal umbilical vein remains closed and that small paraumbilical channels open in response to high portal pressure. The terms paraumbilical vein and umbilical vein are often used interchangeably in clinical practice. Doppler detects the presence and direction of flow within the paraumbilical vein. Flow in this vein is hepatofugal, or away from the liver (Fig. 4 ). Color or power Doppler is helpful in demonstrating the course of the vein toward the umbilicus (Fig. 5 ). This finding of normal (hepatopetal) flow through the main portal vein into the liver and hepatofugal flow in the paraumbilical vein was first described in 1833. It is associated with severe portal hypertension. 9 This phenomenon has been called Cruveilhier-Baumgarten syndrome after two of the early researchers of this condition. The literature is full of debate on the potential protective nature of the paraumbilical veins in preventing esophageal varices. It does not appear that this is the case, however, since some patients with patent paraumbilical veins still develop esophageal varices and bleeding. 3, 8, 9 A third collateral pathway is via the left gastric or coronary vein. This vein normally brings blood from the esophagus to the portal confluence. This vein is infrequently seen in normal patients. It dilates in portal hypertension, enhancing sonographic visualization. A diameter greater than 0.7 cm is associated with severe portal hypertension. 3, 8 The most important change, however, is in the direction of blood movement within this vein. It reverses in portal hypertension and diverts blood from the portal vein toward the esophagus. Color Doppler confirms the direction of blood flow in this vein. Bleeding from fragile varices in the distal esophagus is often a fatal event for the patient. 2 There are other subtle sonographic features suggestive of portal hypertension including portal vein dilation, lack of portal respiratory changes, and prominent hepatic arteries. However, these features alone are insufficient for diagnosing portal hypertension. The main portal vein may dilate with portal hypertension. A vein diameter of greater than or equal to 12.5 mm has been associated with portal hypertension. 3, 6, 10 It dilates as the portal pressure rises, similar to the way in which a river behind an obstruction gets larger. However, the formation of varices that divert blood away from the liver decompresses the portal system. It is for this reason that portal vein size is an unreliable indicator of portal hypertension.
Respiratory variation in the portal vein decreases with portal hypertension. The portal vein normally increases in size and flow by 20% or more with inspiration. 3, 10, 11 Normal pulsed-wave Doppler demonstrates an undulating pattern with small changes in velocity with respiration. The effects of respiration are dampened by high pressure within the portal system, which reduces the portal vein size variation and makes the wave pattern flatter. It is difficult to appreciate portal vein size variation in normal patients and therefore impractical in the difficult-to-image cirrhotic population.
Blood flow patterns into the liver change with portal hypertension. The normal ratio of 75% portal venous blood and 25% hepatic arterial blood reverses as portal venous pressure rises. This causes the hepatic arteries to become more prominent when imaging. At first glance, it may appear that the patient has intrahepatic biliary dilation because double tubes are seen running through the liver. Doppler confirms that the tubes represent portal veins and hepatic arteries. Bile ducts do not demonstrate flow with Doppler.
A late finding in portal hypertension is flow reversal in the main portal vein. The portal vein and hepatic artery are both normally hepatopetal and either both red or both blue depending on the flow direction relative to the transducer. The portal vein and hepatic artery become displayed in different colors, one red and the other blue, when the portal vein flow direction reverses (Fig. 6 ). The portal pressure within the liver is so high in these patients that blood enters the liver through the hepatic artery and leaves via the portal vein. The likelihood of this phenomenon occurring increases as the severity of cirrhosis increases. 5
Treatment Options
Treatment options are divided into those that cure the disease and those that offer palliation. The definitive cure is liver transplant because the process of cirrhosis is irreversible once started. Transplant survival is improving, but demand for transplant livers continues to outpace the supply of available organs. Most patients undergo palliative treatment. These treatments center on the reduction of risk for upper gastrointestinal bleeding and the management of active bleeds. 2 Bleeding occurs as a result of the rupture of esophageal varices.
Esophageal bleeding is the most life-threatening complication of portal hypertension. Approximately one third of patients with esophageal varices will bleed, and half of these patients will die upon presentation with their first bleed. 2 Most of the survivors will rebleed. There are several options for prevention and treatment of esophageal bleeding. Endoscopy is usually performed first, either during the bleeding phase or subsequently to reduce the risk of future bleeds. The endoscopist uses banding or sclerotherapy techniques to eradicate esophageal varices. Banding involves ligating the varices with rubber bands to prevent bleeding. Sclerotherapy involves injection of chemicals into the varices that cause them to harden and close. These procedures are often performed multiple times for each patient. 2 Drugs are also used in the treatment of portal hypertension. β-blockers reduce the risk of a first bleed or subsequent bleeds. β-blockers such as propranolol block the response of the sympathetic nervous system, slowing down the heart rate and force of cardiac contraction. Nitrates are also used.
The palliative technique of most importance for sonographers is the transjugular intrahepatic portosystemic shunt (TIPSS) procedure. The TIPSS procedure is attempted in patients with persistent varices following unsuccessful endoscopic banding and/or sclerotherapy, and for refractory ascites. [1] [2] [3] 12 Rosch performed the first TIPSS procedure on animals in 1969. The first human TIPSS was inserted in 1982. 1 The shunt creates a direct pathway from the portal to the systemic system, bypassing the liver. The goal is to reduce the portal systemic gradient to less than 12 mm Hg or 20% below the baseline gradient. 1, 2 The lower gradient is thought to reduce the risk of formation of esophageal varices.
A TIPSS is inserted under fluoroscopic guidance. 1 A catheter is inserted into the right internal jugular vein and threaded through the right atrium, into the IVC, and into the most easily accessible hepatic vein. This is usually the right hepatic vein owing to its orientation relative to the IVC. The needle is then punched through into the closest portal vein, often the right portal vein. An angioplasty balloon dilates the needle tract, allowing for the insertion of one or more expandable metallic shunts that create a permanent shunt between the portal and systemic systems. Pressure recordings in the hepatic and portal venous system are documented. Shunts are typically 8 to 12 mm in diameter.
Sonography is invaluable in the follow-up of patients with TIPSS. 1, 12 Sonography is used to identify shunt location and patency and to search for reaccumulation of ascites that may indicate shunt failure. The shunt is an echogenic tubular structure. The scan plane varies depending on the orientation of the shunt. Doppler is essential in assessing the presence and direction of blood flow within the shunt. Color Doppler is used to assess both these criteria. Normal direction of flow within the shunt is toward the hepatic veins and IVC (Fig. 7A ). 3 Pulsed-wave Doppler is used to assess the velocity through the shunt (Fig. 7B ). Doppler samples are taken at the inflow (portal) end, midshunt, and outflow (hepatic vein) end. 3 The angle-correct function must be employed because peak velocity information is required. A normal TIPSS waveform shows variation with the cardiac cycle, more like a hepatic venous than a portal venous profile. This is the result of the proximity of this tube to the right atrium. Average velocity in a TIPSS is higher than in a normal portal or hepatic vein. This is a reflection of the high portal systemic gradient. Typical velocities in the shunt are reported to range from 65 to 200 cm/s. 3, 13 Two major complications of the TIPSS procedure are insufficiency and encephalopathy. One-year shunt insufficiency resulting from stenosis or thrombosis is reported to be as high as 87%. 1, 12 Early failure is often due to shunt thrombosis. Later stenosis is a result of progressive intimal hyperplasia. Stenosis most often occurs at the hepatic end of the shunt. 12 Doppler can be used for the noninvasive detection of shunt insufficiency. Color Doppler can detect stenosis or occlusion within the shunt, although it is often technically difficult to perform. It is recommended that sonographers confirm flow in adjacent vessels prior to documenting an occlusion. Pulsed-wave Doppler is used to record and monitor shunt velocities. There are four Doppler features that are consistent with shunt insufficiency. These parameters are used in Vancouver and are similar to those reported by Kanterman et al. 13 A serial increase or decrease in shunt velocity of more than 50 cm/s or less than 90 cm/s is indicative of stenosis or impending thrombosis. Another sign of insufficiency is a reduction in main portal vein flow to less than 60 cm/s. Flow reversal in the right and left portal veins can be detected with pulsed-wave or color Doppler. Patients who have undergone TIPSS procedures normally have hepatofugal flow in these veins, with blood diverted toward the shunt. Reversal to a hepatopetal pattern is associated with shunt stenosis. Reaccumulation of ascites or the formation of new varices may be seen with 2D imaging as shunts fail. The main features of shunt failure are outlined in Table 1 . A consequence of the TIPSS procedure is an increased incidence of encephalopathy. The exact incidence is difficult to assess but is reported in 12% to 50% of patients. 1, 2 Encephalopathy occurs when blood is diverted directly from the portal to the systemic system, missing the opportunity for processing in the liver. Blood containing metabolites from the gut is sent through the heart and directly to the brain, resulting in neurologic symptoms. Patients with encephalopathy are confused, easily agitated, and often uncooperative. Encephalopathy can be treated medically with protein restriction and lactulose. 1 A series of studies has compared the outcomes of endoscopic treatment against the TIPSS procedure. They are summarized by Ong and colleagues 1 and Stanley and Hayes. 2 Rebleeding rates are lower with TIPSS, but the incidence of encephalopathy is higher. Overall, 1-year survival for both techniques is comparable. The advantages and disadvantages of the options must be weighed for each patient circumstance.
Limitations of Sonography
Sonography is important in the diagnosis of portal hypertension. 2D imaging can detect the etiology and secondary features of portal hypertension. Doppler imaging identifies the presence and direction of flow in portal vessels and varices. There are limitations to the technique that are important to delineate.
The main limitation is the inability to directly measure portal venous pressure and gradients within the liver. Haag et al. 6 attempted to predict portal pressure and portosystemic gradients with Doppler. Doppler samples were compared with pressures obtained from venography, the gold standard. Haag et al. obtained only weak correlation and concluded that although Doppler is useful in the diagnosis of portal hypertension, it does not allow for grading of severity of the condition. The presence of collateral venous pathways is thought to confound the portal hemodynamics.
Another limitation is the technical difficulty of imaging patients with cirrhosis. Many of these patients have small attenuating livers and massive ascites that make their abdomens large and place the liver deep in the sonographic field. It can be difficult to sample the portal vessels in these livers. The orientation and angulation of the TIPSS procedure make it difficult to record flow velocities. Patients may be uncooperative due to encephalopathy. Sonographers must employ all their technical expertise to overcome these obstacles.
Conclusion
Portal hypertension is a serious condition. The most common precursor to portal hypertension in the Western world is cirrhosis, although it may result from other conditions. 2D sonography can be used to document the etiology and secondary features of the disease. Doppler is useful to detect the presence and direction of flow within the portal system and varices but cannot determine the severity of the disease. The TIPSS procedure is used as a palliative measure to reduce the risk of often fatal bleeding caused by esophageal varices.
This article has described many sonographic features of portal hypertension. Sonographers are reminded to always use multiple sonographic parameters in combination with patient history for best results.
TABLE 1 Sonographic Findings of Transjugular Intrahepatic Portosystemic Shunt Insufficiency
Serial increase or decrease in velocity of more than 50 cm/s Velocity less than 90 cm/s Main portal vein velocity less than 60 cm/s Hepatopetal flow in the right and left portal veins Reappearance of ascites or varices
